AAPL 188.99 -0.13 (-0.07%)MSFT 128.09 -0.03 (-0.02%)FB 185.32 +0.01 (+0.01%)ZNGA 6.19 -0.01 (-0.16%)NVDA 156.55 +0.3 (+0.19%)WBA 52.27 -0.05 (-0.09%)GOOG 1161.8 -0.53 (-0.05%)PIH 5.82 +0.25 (+4.49%)
AAPL 188.99 -0.13 (-0.07%)MSFT 128.09 -0.03 (-0.02%)FB 185.32 +0.01 (+0.01%)ZNGA 6.19 -0.01 (-0.16%)NVDA 156.55 +0.3 (+0.19%)WBA 52.27 -0.05 (-0.09%)GOOG 1161.8 -0.53 (-0.05%)PIH 5.82 +0.25 (+4.49%)

Company Profile IFRX Quote InflaRx N.V

InflaRx N.V. Quote

InflaRx N.V. (IFRX)

40.21 0.2 Healthcare

CEO

Niels Riedemann

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.